Delphinidin and Survival After Cardiac Arrest in Mice
Author Information
Author(s): Bajorat Rika, Grest Stella Line, Bergt Stefan, Klawitter Felix, Vollmar Brigitte, Reuter Daniel A.
Primary Institution: Rostock University Medical Center
Hypothesis
Administration of delphinidin immediately after CA-CPR could attenuate systemic inflammation and improve survival and long-term outcomes.
Conclusion
Delphinidin treatment did not improve survival after cardiac arrest and may have led to increased mortality.
Supporting Evidence
- Delphinidin treatment resulted in significantly lower survival rates compared to controls.
- Anxiety-like behavior increased in both treatment groups after resuscitation.
- Delphinidin did not show any significant improvement in neurological outcomes.
Takeaway
The study tested a substance called delphinidin to see if it could help mice survive after a heart attack, but it actually made things worse.
Methodology
Mice were divided into control and delphinidin-treated groups, with survival and neurological outcomes assessed after cardiac arrest and resuscitation.
Potential Biases
Small sample size and early termination may introduce bias in the results.
Limitations
Higher mortality in the delphinidin group led to early termination of the study, limiting data on short-term recovery.
Participant Demographics
Female wild-type mice (C57BL/6J), approximately 4-5 months old.
Statistical Information
P-Value
0.036
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website